P. Moreau, S. Miguel, J. Sonneveld, P. Mateos, M. V. Zamagni et al., Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol, vol.28, issue.suppl_4, pp.52-61, 2017.

A. Palumbo, H. Avet-loiseau, S. Oliva, H. M. Lokhorst, H. Goldschmidt et al., Revised international staging system for multiple myeloma: a report from international myeloma working group, J Clin Oncol Off J Am Soc Clin Oncol, vol.33, pp.2863-2872, 2015.

S. K. Kumar, S. V. Rajkumar, A. Dispenzieri, M. Q. Lacy, S. R. Hayman et al., Improved survival in multiple myeloma and the impact of novel therapies, Blood, vol.111, pp.2516-2536, 2008.

P. Moreau and C. Touzeau, Multiple myeloma: from front-line to relapsed therapies, Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Meet, vol.2015, pp.504-515

C. Touzeau, P. Moreau, and C. Dumontet, Monoclonal antibody therapy in multiple myeloma, Leukemia, vol.31, pp.1039-1086, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01795709

N. Raje, J. Berdeja, Y. Lin, D. Siegel, S. Jagannath et al., Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma, N Engl J Med, vol.380, pp.1726-1763, 2019.

S. K. Kumar, M. A. Dimopoulos, E. Kastritis, E. Terpos, H. Nahi et al., Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study, 2017.

M. Gerlinger, A. J. Rowan, S. Horswell, M. Math, J. Larkin et al., Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N Engl J Med, vol.366, pp.883-92, 2012.

R. Fonseca and J. Hinkel, Value and cost of myeloma therapy-we can afford it, Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet, pp.647-55, 2018.

P. Allart-vorelli, B. Porro, F. Baguet, A. Michel, and F. Cousson-gélie, Haematological cancer and quality of life: a systematic literature review, Blood Cancer J, vol.5, p.305, 2015.

S. V. Rajkumar, M. A. Dimopoulos, A. Palumbo, J. Blade, G. Merlini et al., International myeloma working group updated criteria for the diagnosis of multiple myeloma, Lancet Oncol, vol.15, pp.538-586, 2014.

J. E. Ware, SF-36 health survey update, Spine, vol.25, pp.3130-3139, 2000.

, EuroQol--a new facility for the measurement of healthrelated quality of life, Health Policy Amst Neth, vol.16, pp.199-208, 1990.

S. Kumar, J. L. Kaufman, C. Gasparetto, J. Mikhael, R. Vij et al., Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01631468

B. Tessoulin, G. Descamps, P. Moreau, S. Maïga, L. Lodé et al., PRIMA1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance, Blood, vol.124, pp.1626-1662, 2014.

E. Z. Macosko, A. Basu, R. Satija, J. Nemesh, K. Shekhar et al., Highly parallel genome-wide expression profiling of individual cells using Nanoliter droplets, Cell, vol.161, pp.1202-1216, 2015.

P. Gomez-bougie, M. S. Tessoulin, B. Bourcier, J. Bonnet, A. Rodriguez et al., BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment, Blood, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01900681

C. Touzeau, J. Ryan, J. Guerriero, P. Moreau, T. N. Chonghaile et al., BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics, Leukemia, vol.30, pp.761-765, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01411102

M. Hanf, D. Chiron, S. De-visme, C. Touzeau, H. Maisonneuve et al., The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma, BMC Cancer, vol.16, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01381110

S. Kumar, B. Paiva, K. C. Anderson, B. Durie, O. Landgren et al., International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma, Lancet Oncol, vol.17, pp.328-374, 2016.

N. J. Devlin, D. Parkin, and J. Browne, Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data, Health Econ, vol.19, pp.886-905, 2010.

J. Honaker, G. King, M. Blackwell, and I. I. Amelia, A program for missing data, J Stat Softw, vol.45, pp.1-47, 2011.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations